Skip to main content

Table 2 The differences of the disease duration, the H&Y stage, the L-dopa equivalent dose, and the UPDRS scores and subscores among PDSS-identified sleep disturbances

From: Tremor and clinical fluctuation are related to sleep disorders in Chinese patients with Parkinson’s disease

items

Groups

Score ≤ 90 (n = 26)

 

91 ~ 104(n = 24)

 

≥105(n = 86)

 

Mean (SD)

Min-Max

Mean (SD)

Min-Max

Mean (SD)

Min-Max

Male. n (%)

15(17.6)

15(17.6)

55(64.7)

Age at visit, years

63.42(2.68)

34-87

70.42(1.48)

51-88

62.71(1.22)

29-80

Age at onset, years

54.21(2.84)

27.5-81

64.54(1.97)

40-81

57.68(1.27)

27.5-78

Disease duration**

9.21(6.14)

0.5-27

5.88(5.59)

1-27

5.03(4.09)

0.5-20

H&Y stage**

2.62(0.90)

1-4

2.38(0.77)

1-4

1.95(0.75)

1-4

Levodopa*

494(208)

100-950

339(233)

0-786

360(261)

0-1196

UPDRS score**

56.19(29.93)

19-141

48.46(26.75)

18-121

36.72(17.36)

10-111

Daily life activity*

16.85(8.68)

6-41

14.96(8.93)

6-37

11.44(5.11)

3-33

Motor function**

36.27(21.06)

3-91

32.33(18.27)

10-83

24.00(12.30)

4-73

Tremor*

5.96(5.42)

0-20

5.58(3.87)

0-15

3.53(3.05)

0-14

Rigidity**

8.46(4.55)

0-19

6.17(4.58)

0-17

5.26(3.44)

0-15

bradykinesia

13.54(8.58)

1-30

12.04(8.61)

1-36

9.27(6.23)

0-36

Gait/postural stability*

5.23(3.73)

0-15

5.38(3.82)

0-16

3.61(2.95)

0-16

Bulbar abnormalities**

3.08(1.35)

1-7

3.17(1.63)

0-8

2.33(0.99)

0-5

Complication**

3.08(2.62)

0-9

1.17(1.09)

0-4

1.28(1.97)

0-11

Motor fluctuation**

1.46(1.96)

0-7

0.04(0.2)

0-1

0.44(1.06)

0-4

Dyskinesia

0.50(1.03)

0-4

0.17(0.64)

0-3

0.26(0.84)

0-6

  1. *:p < 0.05; **:p < 0.01. Kruskal-Wallis Test, max = maximum; min = minimum.